MABE362 Sigma-AldrichAnti-EZH2 Antibody, clone AE25
This Anti-EZH2 Antibody, clone AE25 is validated for use in Western Blotting, IHC for the detection of EZH2.
More>> This Anti-EZH2 Antibody, clone AE25 is validated for use in Western Blotting, IHC for the detection of EZH2. Less<<Produits recommandés
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H | WB, IHC | M | Purified | Monoclonal Antibody |
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Control |
|
| Presentation | Purified mouse monoclonal IgG1κ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
| Quality Level | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
| Packaging Information | |
|---|---|
| Material Size | 100 µL |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN |
| MABE362 | 04053252551819 |
Documentation
Anti-EZH2 Antibody, clone AE25 FDS
| Titre |
|---|
Anti-EZH2 Antibody, clone AE25 Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| Anti-EZH2, clone AE25 - 2458016 | 2458016 |
| Anti-EZH2, clone AE25 - 3472441 | 3472441 |
| Anti-EZH2, clone AE25 - 3698189 | 3698189 |
| Anti-EZH2, clone AE25 - 4154506 | 4154506 |
| Anti-EZH2, clone AE25 - Q2062626 | Q2062626 |
| Anti-EZH2, clone AE25 -2572523 | 2572523 |
| Anti-EZH2, clone AE25 -2621117 | 2621117 |
| Anti-EZH2, clone AE25 Monoclonal Antibody | 3048308 |
| Anti-EZH2, clone AE25 Monoclonal Antibody | 2902715 |
Références bibliographiques
| Aperçu de la référence bibliographique | Nº PubMed |
|---|---|
| EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Pietersen, Alexandra M, et al. Breast Cancer Res., 10: R109 (2008) 2008 Afficher le résumé | 19099573
![]() |




